Back to Search Start Over

Nivolumab Versus Investigator'S Choice (IC) for Platinum-Refractory Recurrent or Metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN; CHECKMATE 141) : Outcomes in First-Line R/M Patients and Updated Safety and Efficacy

Authors :
Gillison, M. L.
Blumenschein, G.
Fayette, J.
Guigay, J.
Colevas, A. D.
Licitra, L.
Harrington, K. J.
Kasper, S.
Vokes, E. E.
Even, C.
Worden, F.
Saba, N. F.
Docampo, LCI
Haddad, R.
Rordorf, T.
Kiyota, N.
Tahara, M.
Lynch, M.
Kopit, J.
Ferris, R. L.
Publication Year :
2017

Subjects

Subjects :
Medizin

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.unidue...bib..88d681c778e7a1d58d9fef0f30f2ce01

Tools

Authors Abstract Subjects Details